- Home
- CABO vs IMCR Comparison
CABO vs IMCR Comparison
Compare CABO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- IMCR
- Stock Information
- Founded
- CABO 1980
- IMCR 2008
- Country
- CABO United States
- IMCR United Kingdom
- Employees
- CABO N/A
- IMCR N/A
- Industry
- CABO Cable & Other Pay Television Services
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CABO Telecommunications
- IMCR Health Care
- Exchange
- CABO Nasdaq
- IMCR Nasdaq
- Market Cap
- CABO 748.3M
- IMCR 1.8B
- IPO Year
- CABO N/A
- IMCR 2021
- Fundamental
- Price
- CABO $172.03
- IMCR $35.24
- Analyst Decision
- CABO Hold
- IMCR Buy
- Analyst Count
- CABO 3
- IMCR 8
- Target Price
- CABO $171.00
- IMCR $57.00
- AVG Volume (30 Days)
- CABO 125.0K
- IMCR 281.5K
- Earning Date
- CABO 11-06-2025
- IMCR 11-05-2025
- Dividend Yield
- CABO 3.43%
- IMCR N/A
- EPS Growth
- CABO N/A
- IMCR N/A
- EPS
- CABO N/A
- IMCR N/A
- Revenue
- CABO $1,542,441,000.00
- IMCR $356,145,000.00
- Revenue This Year
- CABO N/A
- IMCR $31.83
- Revenue Next Year
- CABO N/A
- IMCR $8.50
- P/E Ratio
- CABO N/A
- IMCR N/A
- Revenue Growth
- CABO N/A
- IMCR 26.78
- 52 Week Low
- CABO $117.54
- IMCR $23.15
- 52 Week High
- CABO $437.00
- IMCR $39.33
- Technical
- Relative Strength Index (RSI)
- CABO 60.98
- IMCR 56.75
- Support Level
- CABO $156.35
- IMCR $35.33
- Resistance Level
- CABO $169.00
- IMCR $37.16
- Average True Range (ATR)
- CABO 7.52
- IMCR 1.36
- MACD
- CABO 0.71
- IMCR 0.32
- Stochastic Oscillator
- CABO 73.52
- IMCR 53.39
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.